Walnut Shell Glasses Moxibustion for Dry Eye Syndrome

Dry Eye Clinical Trial

Official title:

Walnut Shell Glasses Moxibustion for Dry Eye Syndrome: a Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03116776
• Other study ID #: 2016-121-KY-01
• Status: Recruiting
• Phase: N/A
• Start date: May 1, 2017
• Est. completion date: December 30, 2018

Study information

• Verified date: July 2018
• Source: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Contact: Weiwei Fu
• Phone: +86-15201309895
• Email: fuweiwei_vm[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This trial is designed to evaluate the efficacy of walnut shell glasses moxibustion for dry eye syndrome compared with sodium hyaluronate eye drops.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 128
• Est. completion date: December 30, 2018
• Est. primary completion date: July 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

1. eyes are in line with dry eye diagnostic criteria.

2. Age 18 to 75 years,

3. signed informed consent, voluntary adherence to treatment for more than 1 month.

Exclusion Criteria:

1. combined with other eye disease (such as conjunctiva, cornea and iris have significant lesions).

2. eye surgery within 3 months.

3. pregnant or lactating women.

4. oral the drugs which could inhibit lacrimal gland secretion.

5. severe meibomian gland dysfunction.

6. severe eye burns, chemical injury patients.

7. combined with cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other serious primary disease, mental patients.

8. patients with Sjogren's syndrome.

9. patients who are participating in other drug clinical trials.

10. patients who are using other drugs or therapies for the treatment of dry eyes.

Related Conditions & MeSH terms

• Dry Eye
• Dry Eye Syndromes
• Keratoconjunctivitis Sicca

Intervention

Procedure:
• Walnut Shell Glasses Moxibustion
Participants in experimental group will receive 12 sessions of walnut shell glasses moxibustion, each for 30 minutes,3 times per week, and administered over 4 weeks.

Drug:
• Sodium hyaluronate eye drops
One drop for each eye, four times per day for over 4 weeks.

Locations

Country	Name	City	State
China	Guang'anmen Hospital, China Academy of Chinese Medical Sceince	Beijing	Beijing
China	Guang'anmen Hospital, China Academy of Chinese Medical Science	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change from baseline in OSDI score	We use the ocular surface disease index(OSDI) to evaluate the degree of dry eye. Assessing time point: at week 4, week 16, week 28.	week 4, week 16, week 28
Secondary	the efficacy of Walnut Shell Glasses Moxibustion	The proportion of patients whose OSDI score reduced more than 50%	week 4, week 16, week 28
Secondary	change from baseline in mean weekly OSDI score	The mean weekly OSDI score over weeks 1-4 will be calculated as as the sum of each week divided by the number of weeks assessed.	week 1-4, week 16, week 28
Secondary	change from baseline in VAS of eye discomfort	Eye discomfort VAS scale: for the eye symptoms of self-assessment. Dry eye symptoms include itching, foreign body sensation, burning sensation, pain, dry, blurred vision, photophobia, eye swelling, tear Crack,ect. The overall discomfort are evaluate by VAS . Uses a 100-mm line that is labeled at each end. 0 mm represents no eye discomfort, 100 mm represents the most intolerable eye discomfort. Patient will rate the VAS(average VAS in the past 24h three times a week).	week 4, week 16, week 28
Secondary	change from baseline in mean daily VAS score	Patients will rate their average eye comfort with VAS three times a week. The mean daily VAS over week 1-4 will be calculated as the sum of each day divided by the number of days assessed.	week 1-4, week 16, week 28
Secondary	change from baseline in BUT	Check the tear break time(BUT) should be carried out before the other steps in the operation of the eye, used to evaluate the stability of the tear film. In the room without air flow, 1% of the sodium fluorescein with a glass rod dipped in a little coating in the lower eyelid conjunctival sac, the patient after several times, through the slit lamp cobalt blue light wide band inspection tear film, with a stopwatch Record the last time after the completion of the first blink of an eye to open to the tear film appeared in the first randomly distributed dry spots or black lines of time, recorded three times to take the mean.	week 2, week 4
Secondary	change from baseline in Schimer?text	Evaluation the tear secretion, do not use ocular surface anesthetic, measuring the amount of reflex tear secretion. Place the test paper in the middle and outer 1/3 of the conjunctiva of the lower eyelid, and instruct the patient to lighten his eyes or look down at the bottom, and remove it after 5 minutes to measure the wetness from the beginning of the bend.	week 2, week 4
Secondary	change from baseline in corneal fluorescence staining scores	Corneal fluorescein staining: 2% fluorescein sodium coated with glass rods in the conjunctival sac, observed under the slit lamp to observe whether the corneal epithelium with staining, such as yellow-green stained, suggesting that corneal epithelial cell integrity damage. Score by 12 points. Cornea was divided into 4 quadrants, each quadrant was 0-3, no staining was 0, 1 to 30 dotted was 1 point, > 30 dotted but not fused For 2 points, 3 points for the emergence of corneal punctate staining, filaments and ulcers.	week 2, week 4
Secondary	patiant's expectations for moxibustion	This questionnaire includes three brief questions to investigate whether patients believe that moxibustion treatment will be useful. The relationship between patients' expectations and the effectiveness of moxibustion will be investigated because patients' beliefs about treatment enhanced or attenuated the effectiveness of treatment in a previous experimental study .	baseline